Rheumatoid arthritis, connective tissue and inflammatory bowel diseases, in particular

Long term exposure to air pollution is linked to a heightened risk of autoimmune disease, particularly rheumatoid arthritis, connective tissue and inflammatory bowel diseases, finds research published online in the open access journal RMD Open.

Environmental air pollution from vehicle exhaust and industrial output can trigger adaptive immunity–whereby the body reacts to a specific disease-causing entity. But sometimes this adaptive response misfires, prompting systemic inflammation, tissue damage, and ultimately autoimmune disease. 

Examples of autoimmune disease include rheumatoid arthritis; systemic lupus erythematosus; inflammatory bowel diseases, such as ulcerative colitis; connective tissue disease, such as osteoarthritis; and multiple sclerosis.

Both the incidence and prevalence of these conditions have steadily increased over the past decade, the reasons for which aren’t entirely clear. And whether air pollution is linked to a heightened risk of autoimmune disease remains a matter of debate, say the researchers.

To try and shed some light on the issues, the researchers mined the national Italian fracture risk database (DeFRA) and retrieved comprehensive medical information on 81,363 men and women submitted by more than 3500 doctors between June 2016 and November 2020.

Most were women (92%) with an average age of 65, and 17866 (22%) had at least one co-existing health condition. 

Each participant was linked to the nearest air quality monitoring station run by the Italian Institute of Environment Protection and Research via their residential postcode. 

The researchers were particularly interested in the potential impact of particulate matter (PM10 and PM2.5). Levels of 30µg/m3 for PM10 and 20µg/m3 for PM2.5 are the thresholds generally considered harmful to human health.

Some 9723 people (12%) were diagnosed with an autoimmune disease between 2016 and 2020.

Information on air quality was obtained from 617 monitoring stations in 110 Italian provinces. Average long term exposure between 2013 and 2019 was 16 µg/m3 for PM2.5 and 25 µg/m3 for PM10.

Exposure to PM2.5  wasn’t associated with a heightened risk of an autoimmune disease diagnosis. But PM10 was associated with a 7% heightened risk for every 10µg/m3 increase in levels, after accounting for potentially influential factors.

Long term exposure to PM10 above 30 µg/m3 and to PM2.5 above 20 µg/m3 were associated with, respectively, a 12% and 13% higher risk of autoimmune disease. 

And long term exposure to PM10 was specifically associated with a heightened risk of rheumatoid arthritis, while long term exposure to PM2.5 was associated with a heightened risk of rheumatoid arthritis, connective tissue diseases, and inflammatory bowel diseases.

Overall, long term exposure to traffic and industrial air pollutants was associated with an approximately 40% higher risk of rheumatoid arthritis, a 20% higher risk of inflammatory bowel disease, and a 15% higher risk of connective tissue diseases.

This is an observational study, and as such, can’t establish cause. And the researchers acknowledge several limitations which might have affected their findings.

These include: the lack of information on the dates of diagnosis and start of autoimmune disease symptoms; that air quality monitoring might not reflect personal exposure to pollutants; and that the findings might not be more widely applicable because study participants largely comprised older women at risk of fracture. 

But air pollution has already been linked to immune system abnormalities, and smoking, which shares some toxins with fossil fuel emissions, is a predisposing factor for rheumatoid arthritis, they explain.

Notes for editors Research: Association between long-term exposure to air pollution and immune mediated diseases: a population-based cohort study doi 10.1136/rmdopen-2021-002055 Journal: RMD Open

Link to AMS labelling system: https://press.psprings.co.uk/AMSlabels.pdf 

Externally peer reviewed? Yes Evidence type: Observational Subjects: People

If you are a journalist needing to speak to an expert, please click here.

Latest coverage of BMJ in the national and international media

If you are a journalist who would like to receive our press releases, please provide your details.

Email the UK media relations team for more information.

London, UK head office BMJ BMA House Tavistock Square London WC1H 9JR United Kingdom

Switchboard: +44 (0)203 655 5997 Customer Service: +44 (0) 20 7111 1105 Email: support@bmj.com

Beijing, China Room 335 Hyundai Motor Tower 38 Xiaoyun Road Chaoyang District Beijing, 100027 China

Telephone 1: +86 (10) 64100686 Telephone 2: +86 (10) 64100685 Email: info.china@bmj.com

Mumbai, India BMJ 102, Navkar Chamber, A Wing Marol, Andheri - Kurla Road Andheri (East) Mumbai- 400059

Tel: 022-40260312/13/14 Email: sbasu@bmj.com

Noida, India BMJ Group India Pvt. Ltd. IT TOWER, 3rd Floor, Plot No. FC-24, , Sector-16 A, Film city Noida, U.P - 201301

Tel: +91 120 4345733 Email: sbasu@bmj.com

New Jersey, North America BMJ Publishing Inc Two Hudson Place Hoboken, NJ 07030

Tel: 1- 855-458-0579 Email: ussupport@bmj.com

Cardiff, Wales BMJ 12th Floor, Southgate House Cardiff CF10 1GR Wales, United Kingdom

Tel: +44 (0) 207 111 1105 Email: support@bmj.com